Jaime Zerhusen from 32 Powderock Pl, Baltimore, MD 21236, Phone: (410)2561082

view source

Position:

cell production operations technician, licensed cytotechnologist at Lonza Biosciences

Location:

Baltimore, Maryland Area

Industry:

Biotechnology

Work:

Lonza Biosciences
cell production operations technician, licensed cytotechnologist

view source

Therapeutic Products Comprising Vitalized Placental Dispersions
view source
US Patent:

20140037598, Feb 6, 2014
Filed:

Oct 17, 2013
Appl. No.:

14/056101
Inventors:

Samson Tom - Baltimore MD, US
Alla Danilkovitch - Columbia MD, US
Dana Yoo - Sykesville MD, US
Jaime Zerhusen - Columbia MD, US
Assignee:

Osiris Therapeutics, Inc. - Columbia MD
International Classification:

A61K 35/50
A61K 38/39
A61K 38/57
A61K 38/18
US Classification:

424 937
Abstract:

This invention provides a fluid therapeutic placental product comprising placental cells and a placental dispersion comprising placental factors. The placental cells and the placental dispersion are derived from placental tissue. A placental tissue can optionally be an amnion, chorion, or a trophoblast-depleted chorion. The placental product of the present invention is useful in treating a patient with a tissue injury (e.g. wound or burn) by applying the placental product to the injury. Similar application is useful with ligament and tendon repair and for engraftment procedures such as bone engraftment.

Therapeutic Products Comprising Vitalized Placental Dispersions
view source
US Patent:

20110212064, Sep 1, 2011
Filed:

Feb 18, 2011
Appl. No.:

13/030580
Inventors:

Timothy Jansen - Baltimore MD, US
Samson Tom - Baltimore MD, US
Alla Danilkovitch - Columbia MD, US
Dana Yoo - Sykesville MD, US
Jaime Zerhusen - Columbia MD, US
International Classification:

A61K 35/12
A61P 17/02
US Classification:

424 937
Abstract:

This invention provides a fluid therapeutic placental product comprising placental cells and a placental dispersion comprising placental factors. The placental cells and the placental dispersion are derived from placental tissue. A placental tissue can optionally be an amnion, chorion, or a trophoblast-depleted chorion. The placental product of the present invention is useful in treating a patient with a tissue injury (e.g. wound or burn) by applying the placental product to the injury. Similar application is useful with ligament and tendon repair and for engraftment procedures such as bone engraftment.

Methods Of Manufacture Of Therapeutic Products Comprising Vitalized Placental Dispersions
view source
US Patent:

20110212065, Sep 1, 2011
Filed:

Feb 18, 2011
Appl. No.:

13/030595
Inventors:

Timothy Jansen - Baltimore MD, US
Samson Tom - Baltimore MD, US
Alla Danilkovitch - Columbia MD, US
Dana Yoo - Sykesville MD, US
Jaime Zerhusen - Columbia MD, US
International Classification:

A61K 35/50
A61P 17/02
US Classification:

424 937
Abstract:

This invention provides a fluid therapeutic placental product comprising placental cells and a placental dispersion comprising placental factors. The placental cells and the placental dispersion are derived from placental tissue. A placental tissue can optionally be an amnion, chorion, or a trophoblast-depleted chorion. The placental product of the present invention is useful in treating a patient with a tissue injury (e.g. wound or burn) by applying the placental product to the injury. Similar application is useful with ligament and tendon repair and for engraftment procedures such as bone engraftment.

Methods Of Manufacture Of Immunocompatible Amniotic Membrane Products
view source
US Patent:

20140127317, May 8, 2014
Filed:

Nov 1, 2013
Appl. No.:

14/070035
Inventors:

- Columbia MD, US
Samson Tom - Baltimore MD, US
Alla Danilkovitch - Columbia MD, US
Dana Yoo - Falls Church VA, US
Jaime Zerhusen - Columbia MD, US
Assignee:

Osiris Therapeutics, Inc. - Columbia MD
International Classification:

A61K 35/50
US Classification:

424583, 435 13
Abstract:

Provided herein is a placental product comprising an immunocompatible amniotic membrane. Such placental products can be cryopreserved and contain viable therapeutic cells after thawing. The placental product of the present invention is useful in treating a patient with a tissue injury (e.g. wound or burn) by applying the placental product to the injury. Similar application is useful with ligament and tendon repair and for engraftment procedures such as bone engraftment.

Jaime Zerhusen